Management of non-small-cell lung cancer (NSCLC) is affected by regional specificities. The present study aimed at determining diagnostic and therapeutic procedures including outcome of patients with NSCLC stage III in the real-world setting in Central European countries to define areas for improvements
ERS Annual Congress, Madrid, Espagneinfo:eu-repo/semantics/publishedsuppl 30,433s (P2912
Introduction: Lung cancer has been the most common cancer in the world and in Belarus. Aim of the...
Through a fourteen years retrospective study of all the patients treated at the State University of ...
The aim of this project was to collect real-world evidence and describe treatment patterns for stage...
Daily-practice challenges in oncology have been intensified by the approval of immune checkpoint inh...
This article analyzes the availability of different diagnostic procedures of non-small cell lung can...
The purpose of this study was to gain insight into the treatment policy and survival of patients wit...
Objectives There is limited data on the pattern of care for locally advanced, clinical (c) IIIB non-...
Background. Endometrial cancer represents a high health burden in Slovenia and worldwide. The incide...
Background: The introduction of targeted treatments for subsets of non-small cell lung cancer (NSCLC...
Background: Care processes for patients with NSCLC can vary by provider, which may lead to unwanted ...
AIMS We present the first analysis of the management and outcomes of stage III non-small cell lun...
Stage III nonsmall cell lung cancer (NSCLC) comprises about one-third of NSCLC patients and is very ...
Although pretreatment evaluations are well defined for the diagnosis of radically treatable NSCLC, w...
<p>Studies evaluating treatment patterns in patients with advanced non-small cell lung cancer by cou...
ERS Annual Congress, Madrid, Espagneinfo:eu-repo/semantics/publishedsuppl 30,433s (P2912
Introduction: Lung cancer has been the most common cancer in the world and in Belarus. Aim of the...
Through a fourteen years retrospective study of all the patients treated at the State University of ...
The aim of this project was to collect real-world evidence and describe treatment patterns for stage...
Daily-practice challenges in oncology have been intensified by the approval of immune checkpoint inh...
This article analyzes the availability of different diagnostic procedures of non-small cell lung can...
The purpose of this study was to gain insight into the treatment policy and survival of patients wit...
Objectives There is limited data on the pattern of care for locally advanced, clinical (c) IIIB non-...
Background. Endometrial cancer represents a high health burden in Slovenia and worldwide. The incide...
Background: The introduction of targeted treatments for subsets of non-small cell lung cancer (NSCLC...
Background: Care processes for patients with NSCLC can vary by provider, which may lead to unwanted ...
AIMS We present the first analysis of the management and outcomes of stage III non-small cell lun...
Stage III nonsmall cell lung cancer (NSCLC) comprises about one-third of NSCLC patients and is very ...
Although pretreatment evaluations are well defined for the diagnosis of radically treatable NSCLC, w...
<p>Studies evaluating treatment patterns in patients with advanced non-small cell lung cancer by cou...
ERS Annual Congress, Madrid, Espagneinfo:eu-repo/semantics/publishedsuppl 30,433s (P2912
Introduction: Lung cancer has been the most common cancer in the world and in Belarus. Aim of the...
Through a fourteen years retrospective study of all the patients treated at the State University of ...